loader
Please Wait
Applying Filters...

List of All Manufacturers & Suppliers of Tofacitinib Citrate Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 16,069Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Dr. Reddy\'s Laboratories

02 2Taro Pharmaceutical Industries

03 1Breckenridge Pharmaceutical

04 2NanoAlvand

05 1Ajanta Pharma Limited

06 2Auro Pharma Inc

07 1Aurobindo Pharma Limited

08 2Bluepharma

09 3DelNova Healthcare

10 3Farmaprojects S.A.U

11 1Hikma Pharmaceuticals

12 2Intas Pharmaceuticals

13 1JAMP PHARMA

14 2Laboratorio Eczane Pharma

15 2MSN Laboratories

16 1Micro Labs Limited

17 17Pfizer Consumer Healthcare

18 11Pfizer Inc

19 1Pharmascience Inc.

20 3Pluviaendo

21 1Prinston

22 2Pulse Pharmaceuticals

23 1Unichem Laboratories Limited

24 2Yaopharma

25 3Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Tofacitinib Citrate

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 22MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Dr Reddy Company Banner

02

arrow
Discovery on Target
Not Confirmed

TOFACITINIB

Brand Name : TOFACITINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 209633

Regulatory Info :

Registration Country : USA

Breckenridge Pharmaceutical

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Tofacitinib Citrate

Brand Name : Rhofanib

Dosage Form : Film Coated Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

04

arrow
Discovery on Target
Not Confirmed

TOFACITINIB (TOFACITINIB CITRATE)

Brand Name : TARO-TOFACITINIB

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 2511304

Regulatory Info : Prescription

Registration Country : Canada

blank

05

arrow
Discovery on Target
Not Confirmed

TOFACITINIB (TOFACITINIB CITRATE)

Brand Name : TARO-TOFACITINIB

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 2511312

Regulatory Info : Prescription

Registration Country : Canada

blank

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Tofacitinib Citrate

Brand Name : Rhofanib

Dosage Form : Film Coated Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

07

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2021-06-01

Application Number : 212943

Regulatory Info : DISCN

Registration Country : USA

blank

08

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : SOLUTION;ORAL

Dosage Strength : EQ 1MG BASE/ML

Packaging :

Approval Date : 2023-09-25

Application Number : 216878

Regulatory Info : RX

Registration Country : USA

blank

09

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2023-03-13

Application Number : 209738

Regulatory Info : DISCN

Registration Country : USA

blank

10

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2012-11-06

Application Number : 203214

Regulatory Info : RX

Registration Country : USA

blank

11

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2018-05-30

Application Number : 203214

Regulatory Info : RX

Registration Country : USA

blank

12

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 11MG BASE

Packaging :

Approval Date : 2016-02-23

Application Number : 208246

Regulatory Info : RX

Registration Country : USA

blank

13

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 22MG BASE

Packaging :

Approval Date : 2019-12-12

Application Number : 208246

Regulatory Info : RX

Registration Country : USA

blank

14

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB CITRATE

Brand Name : XELJANZ

Dosage Form : SOLUTION;ORAL

Dosage Strength : EQ 1MG BASE/ML

Packaging :

Approval Date : 2020-09-25

Application Number : 213082

Regulatory Info : RX

Registration Country : USA

blank

15

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB

Brand Name : TOFACITINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 209923

Regulatory Info :

Registration Country : USA

blank

16

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Tofacitinib

Brand Name : Tofacitinib

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 215552

Regulatory Info :

Registration Country : USA

blank

17

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Tofacitinib

Brand Name : Tofacitinib

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 215552

Regulatory Info :

Registration Country : USA

blank

18

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB CITRATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2023-03-13

Application Number : 209829

Regulatory Info : DISCN

Registration Country : USA

blank

19

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 11MG BASE

Packaging :

Approval Date : 2021-08-19

Application Number : 214264

Regulatory Info : DISCN

Registration Country : USA

blank

20

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

TOFACITINIB CITRATE

Brand Name : TOFACITINIB

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 22MG BASE

Packaging :

Approval Date : 2021-08-19

Application Number : 214264

Regulatory Info : DISCN

Registration Country : USA

blank